3 studies were found.

1.		No longer recruiting	KRN7000 in Treating Patients With Solid Tumors Conditions: Non-small cell lung cancer; unspecified adult solid tumor, protocol specific
2.		No longer recruiting	Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome Conditions: Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
3.		No longer recruiting	Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors Condition: unspecified adult solid tumor, protocol specific